1. Home
  2. ALXO vs CPSS Comparison

ALXO vs CPSS Comparison

Compare ALXO & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.67

Market Cap

240.8M

Sector

Health Care

ML Signal

HOLD

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$9.15

Market Cap

210.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALXO
CPSS
Founded
2015
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
240.8M
210.7M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
ALXO
CPSS
Price
$1.67
$9.15
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
941.0K
23.6K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
26.36
1.27
EPS
N/A
0.24
Revenue
N/A
$434,470,000.00
Revenue This Year
N/A
$147.09
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$39.50
Revenue Growth
N/A
10.41
52 Week Low
$0.41
$6.67
52 Week High
$2.66
$10.49

Technical Indicators

Market Signals
Indicator
ALXO
CPSS
Relative Strength Index (RSI) 35.80 42.45
Support Level $1.54 $7.55
Resistance Level $2.24 $9.58
Average True Range (ATR) 0.11 0.31
MACD -0.04 -0.13
Stochastic Oscillator 2.38 12.36

Price Performance

Historical Comparison
ALXO
CPSS

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

Share on Social Networks: